menu
    • menu

    Company profile for Talem Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Talem Therapeutics (Talem) is a wholly owned subsidiary of ImmunoPrecise Antibodies (IPA) and is focused on the discovery and development of next-generation, fully human, monoclonal, therapeutic antibodies to target multiple disease indications. Using the proprietary antibody discovery platforms and innovative technologies housed at ImmunoPrecise Antibodies, Talem aims to accelerate novel, high-value, therapeutic antibody tre...
    Talem Therapeutics (Talem) is a wholly owned subsidiary of ImmunoPrecise Antibodies (IPA) and is focused on the discovery and development of next-generation, fully human, monoclonal, therapeutic antibodies to target multiple disease indications. Using the proprietary antibody discovery platforms and innovative technologies housed at ImmunoPrecise Antibodies, Talem aims to accelerate novel, high-value, therapeutic antibody treatments to the clinic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Talem TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Broadway, 14th floor Cambridge, MA 02142, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://talemtherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Talem Enters into Collaboration and License Option Agreement with Astellas
    Talem Enters into Collaboration and License Option Agreement with Astellas

    30 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230330005469/en

    BUSINESSWIRE
    30 Mar 2023
    Share Share
    Talem Announces a AI-Driven Antibody Discovery Collaboration with Libera Bio
    Talem Announces a AI-Driven Antibody Discovery Collaboration with Libera Bio

    15 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230315005532/en

    BUSINESSWIRE
    15 Mar 2023
    Share Share
    Talem Therapeutics Licenses Antibodies for Three OmniChicken-Derived Programs
    Talem Therapeutics Licenses Antibodies for Three OmniChicken-Derived Programs

    12 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221012005661/en

    BUSINESSWIRE
    12 Oct 2022
    Share Share
    NIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity
    NIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity

    14 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220914005378/en

    BUSINESSWIRE
    14 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search